Physician profile
Eric M Orenstein
NPI 1174524839
$11,268.88
in general payments reported to CMS, 2019-2025
11 companies · $4,396 in 2025
The $4,396 reported for 2025 was more than what 81% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $167 · 2020: $55.20 · 2021: $125 · 2022: $1,834 · 2023: $4,341 · 2024: $351 · 2025: $4,396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,417 · Food and Beverage: $3,603 · Education: $67.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,416.95 |
| Food and Beverage | $3,603.33 |
| Education | $67.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $7,545.87 | 2021-2025 | Persona, Avenir, Oxford |
| Smith+Nephew, INC. | $2,648.05 | 2023 | Journey, Ri Hip Navigation, Or3o Dual Mobility |
| Stryker Corporation | $352.90 | 2019-2024 | T2 Alpha, Gamma |
| Carbofix Orthopedics INC | $171.23 | 2023 | |
| Medical Device Business Services, INC. | $169.65 | 2023-2025 | Actis |
| Crossroads Orthopedics, LLC | $84.00 | 2024 | |
| Restor3d, INC. | $72.00 | 2024 | |
| Davol INC. | $62.61 | 2024 | Arista Ah Flexitip |
| Heron Therapeutics, INC. | $62.45 | 2025 | Zynrelef |
| Depuy Synthes Sales INC. | $55.20 | 2020 | |
| Pacira Therapeutics, INC. | $44.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Orenstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.